Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06362733 · ClinicalTrials.gov registry record · NA

Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth

A NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT06362733: Recruiting NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.

NCT06362733 is a NA study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by Stanford University. The registered enrollment target is 44 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06362733, a NA study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The purpose of this open label trial is to examine the preliminary feasibility, acceptability, and effectiveness of a 12-week behavioral intervention program (1 hour/week) to treat insistence on sameness (e.g., difficulty tolerating changes in routine) in youth with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of a combination of parent-training and parent-mediated intervention with the child.

Primary Outcome

DARB insistence on sameness subscale scores measure insistence on sameness with higher scores indicating greater intensity of insistence on sameness. \[Score Range: 0-76\]

Interventions

  • BEHAVIORAL Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth

Study Locations (1)

California

  • 401 Quarry Road (Remote Study) - Stanford

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2024-07-11
Est. Completion 2026-07-01
Phase NA
Stanford University

1,744 total trials

What NCT06362733 shows while recruiting

NCT06362733 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (67% lower).

The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth is the first listed.

NCT06362733 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06362733 about?

NCT06362733 is a clinical study titled "Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth". The purpose of this open label trial is to examine the preliminary feasibility, acceptability, and effectiveness of a 12-week behavioral intervention program (1 hour/week) to treat insistence on sameness (e.g., difficulty tolerating changes in routine) in youth with autism spectrum disorder (ASD). T...

What is the current status of trial NCT06362733?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2024-07-11. Estimated completion is 2026-07-01.

What conditions does trial NCT06362733 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Restricted Behavior.

What interventions are being tested in trial NCT06362733?

The interventions under investigation include: Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth (BEHAVIORAL).

Who is sponsoring clinical trial NCT06362733?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06362733 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06362733's enrollment target sits among peer trials

44 151st of 224 higher than 72 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06362733, the US trial registry maintained by the National Library of Medicine. NCT06362733 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.